Iovance Biotherapeutics (IOVA) Stock News Today: Barclays Raises Target, Short-Interest Pressure, and 2026 Catalysts (Dec. 23, 2025)
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is back on traders’ radar heading into Dec. 23, 2025, after a sharp move higher to $2.78 at the Dec. 22 close (up 12.10% on the day) and an early pre-market indication around $2.80. StockAnalysis